Physician profile
Basil Mathews
NPI 1952891087
$7,370.64
in general payments reported to CMS, 2019-2025
13 companies · $3,358 in 2025
The $3,358 reported for 2025 was more than what 88% of Glaucoma Specialist providers received nationally (typical 2025 total: $608).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $308 · 2023: $1,704 · 2024: $2,001 · 2025: $3,358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,063.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,062.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $2,169.96 | 2023-2025 | Clearpath, Streamline, Kahook Dual Blade |
| Abbvie INC. | $1,327.07 | 2023-2025 | |
| Alcon Vision LLC | $994.46 | 2023-2025 | Hydrus Microstent, Simbrinza, Clareon |
| Glaukos Corporation | $690.77 | 2022-2025 | Idosetr, Istent Infinite, Glaucoma Accessory Products |
| Harrow Eye, LLC | $665.65 | 2024-2025 | Vevye |
| Bausch & Lomb Americas INC. | $489.36 | 2022-2025 | Vyzulta, Miebo, Envista Envy Iol |
| Sight Sciences, INC. | $261.82 | 2023-2025 | Omni Surgical System, Sion Surgical Instrument |
| Johnson & Johnson Surgical Vision, INC. | $237.54 | 2025 | Catalys System, Tecnis Iol, Tecnis Iol |
| Rxsight INC | $225.25 | 2023-2025 | Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece |
| Nova Eye, INC. | $148.14 | 2025 | |
| Thea Pharma INC. | $70.12 | 2024 | Iyuzeh |
| Ani Pharmaceuticals, INC. | $65.00 | 2024-2025 | Purified Cortrophin Gel |
| Tarsus Pharmaceuticals, INC. | $25.50 | 2025 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Basil Mathews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.